AI and dermatologists working together on skin lesions
Part of Skin clinical trials.
This trial explores how AI and dermatologists can work together to better identify skin lesions. It aims to see if combining human expertise with AI guidance improves accuracy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a board-certified dermatologist.
- You must have hands-on experience using dermoscopy to diagnose skin lesions.
- Doctors who are still in training (not yet finished their specialization) cannot join.
- Dermatologists without any dermoscopy experience cannot join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an AI tool can help general practitioners diagnose skin conditions as accurately as a dermatologist. If you are an adult whose doctor already used OMNIDOC to send a skin image for expert review, you may be able to take part.
This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.
This study tests a way for doctors to send clear images of your skin spot to be reviewed remotely using teledermoscopy (digital images of the skin). It may help speed up specialist input and improve how skin spots are assessed.
This trial compares two AI approaches to see which one helps doctors diagnose conditions better during remote patient interviews. It may help improve how AI assists healthcare providers.
This trial tests an artificial intelligence system designed to spot skin cancer early. You may be able to join if you are an adult with a suspicious skin spot and can give permission to participate.
This trial tests how well artificial intelligence (AI) helps pathologists make diagnoses from digital tissue images. It may lead to faster and more accurate results for patients like you.
Hear when a new Skin Lesions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.